TrialCancer2020

Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.

Alessandro Rambaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.